NCT04373746

Brief Summary

This is a prospective study that will compare the blood pressure readings from an arterial cannula with those obtained non-invasively by the NICCI device. The study will enroll 50 patients into each of three weight ranges: 10-20 kg, 20-40 kg, and 40-80 kg. The NICCI, Pulsion/GETINGE uses novel technology to provide a continuous estimation of BP displayed as a waveform similar to that seen with an invasive arterial cannula, but is totally non-invasive by using the fingers. The patient rests their hand on the device, which is about the size of a computer mouse, and then a blood pressure cuff goes around their upper arm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P25-P50 for not_applicable surgery

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 4, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

October 26, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

April 18, 2023

Completed
Last Updated

April 18, 2023

Status Verified

March 1, 2023

Enrollment Period

1.2 years

First QC Date

April 22, 2020

Results QC Date

December 20, 2022

Last Update Submit

March 27, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in Blood Pressure

    The absolute difference of the SBP, DBP, and MAP values from the arterial cannula (AC) and NICCI device were calculated. Instead of the directional difference (positive or negative), the absolute difference was used to avoid affecting the data when calculating the mean and standard deviation (SD) of the differences. For instance, if the reading from the NICCI device was 5 mm Hg above or below the reading from the AC, a value of 5 mm Hg was used and not -5 mm Hg or +5 mm Hg.

    2-8 hours (average length of major surgery)

Secondary Outcomes (3)

  • Percentage of BP Values From the NICCI Device That Were ≤ 5 mm Hg the Values Obtained From the AC

    2-8 hours (average length of major surgery)

  • Percentage of BP Values From the NICCI Device That Were ≤ 10 mm Hg the Values Obtained From the AC

    2-8 hours (average length of major surgery)

  • Percentage of BP Values From the NICCI Device That Were > 10 mm Hg From the Values Obtained From the AC

    2-8 hours (average length of major surgery)

Study Arms (2)

10-40 kg

EXPERIMENTAL

Patients undergoing major surgery that weigh between 10-20 kg.

Device: NICCI

40-80 kg

EXPERIMENTAL

Patients undergoing major surgery that weigh between 40-80 kg.

Device: NICCI

Interventions

NICCIDEVICE

Non-invasive beat-to-beat blood pressure monitor capable of producing a waveform similar to an invasive arterial line.

10-40 kg40-80 kg

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients requiring anesthetic care and in whom an indwelling arterial cannula will be placed for the surgical procedure.

You may not qualify if:

  • Patients with history of a peripheral neurologic or neuropathic disorder
  • Patients in whom the upper extremity cannot be used for blood pressure monitoring
  • Patients in whom an invasive arterial cannula cannot be placed
  • Patients with vascular implants at the sites of non-invasive blood pressure measurement (fingers and upper arm of the examined arm)
  • Edematous patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Location

Results Point of Contact

Title
Dr. Joseph D. Tobias
Organization
Nationwide Children's Hospital

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chief, Dept. of Anesthesiology & Pain Medicine

Study Record Dates

First Submitted

April 22, 2020

First Posted

May 4, 2020

Study Start

October 26, 2020

Primary Completion

December 30, 2021

Study Completion

December 30, 2021

Last Updated

April 18, 2023

Results First Posted

April 18, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations